Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis
Affiliation
Division of Cancer Sciences, School of Medical Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health & Manchester Cancer Research Centre, Manchester Academic Health Science Centre (MAHSC), University of Manchester, Manchester, UKIssue Date
2023
Metadata
Show full item recordCitation
Borst GR, Post R. Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis. Journal of neuro-oncology. 2023 Oct 9. PubMed PMID: 37812289. Epub 2023/10/09. eng.Journal
Journal of Neuro-oncologyDOI
10.1007/s11060-023-04457-6PubMed ID
37812289Additional Links
https://dx.doi.org/10.1007/s11060-023-04457-6Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1007/s11060-023-04457-6
Scopus Count
Collections
Related articles
- The use of systemic therapies for the treatment of brain metastases in metastatic melanoma: opportunities and unanswered questions.
- Authors: Murrell J, Board R
- Issue date: 2013 Dec
- Chemotherapy in brain metastases.
- Authors: Peereboom DM
- Issue date: 2005 Nov
- Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.
- Authors: Camidge DR, Lee EQ, Lin NU, Margolin K, Ahluwalia MS, Bendszus M, Chang SM, Dancey J, de Vries EGE, Harris GJ, Hodi FS, Lassman AB, Macdonald DR, Peereboom DM, Schiff D, Soffietti R, van den Bent MJ, Wefel JS, Wen PY
- Issue date: 2018 Jan
- Treatment of brain metastases from melanoma.
- Authors: Legha SS
- Issue date: 2005 May 1
- Systemic chemotherapeutic treatment of patients with breast cancer brain metastases.
- Authors: Liubota R, Vereshchako R, Anikusko M, Liubota I, Vakulenko G
- Issue date: 2021 Jun